Leica Biosystems is a cancer diagnostics company and a global leader in workflow solutions. The company offers a comprehensive product range for each step in the pathology process, from sample preparation and staining to imaging and reporting. As the only company to own the full workflow from biopsy to diagnosis, Leica Biosystems is uniquely positioned to break down the barriers between each step. The company’s mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of its corporate culture.
In the future, Leica Biosystems envisions a world where comprehensive insights enrich cancer diagnoses and offer reassurance to all patients. Currently, the company enables more than 1.6 million diagnoses each week, transforming anxiety into answers for millions of people worldwide.
Leica Biosystems joined Danaher in 2006 and has a rich history of more than 150 years.